The present literature clearly suggests that Classic FMS is not a primary soft-tissue disorder and more likely represents a globally reduced pain threshold caused by central allodynia
These individuals already lose carnitine through dialysis membranes, and if GLP-1-induced appetite changes further reduce their already marginal dietary intake, carnitine status could worsen
Staying hydrated and consuming adequate protein becomes especially important because semaglutide can reduce appetite for all foods, not just calorie-dense ones
Related: Insurance Verification for Weight Loss Medications Cost is one of the biggest concerns for patients researching Mounjaro
The SUSTAIN 1 trial [166] (ClinicalTrials.gov identifier: NCT02054897) was a 30- week, double-blind, randomised, parallel-group, placebo-controlled trial of once-weekly subcutaneous semaglutide 0.5 mg, or semaglutide 1 mg compared with placebo in treatment-naive patients with type 2 diabetes
Not sure if its worth the price